Pharma Industry News

NICE green lights Tremfya to treat active psoriatic arthritis

Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasisOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]